BUDA (NYSEAMERICAN:BUDA) Stock Rating Raised to “Hold” at Zacks Research

Zacks Research upgraded shares of BUDA (NYSEAMERICAN:BUDA – Free Report) to a hold rating in a research report released on Tuesday,Zacks reports.

Separately, Roth Capital initiated coverage on BUDA in a report on Monday. They issued a “buy” rating and a $12.00 target price for the company. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, BUDA has a consensus rating of “Moderate Buy” and a consensus target price of $13.00.

Get Our Latest Research Report on BUDA

BUDA Price Performance

NYSEAMERICAN BUDA opened at $8.20 on Tuesday. The company’s 50-day simple moving average is $8.17 and its 200 day simple moving average is $8.93. BUDA has a twelve month low of $6.25 and a twelve month high of $12.00.

BUDA (NYSEAMERICAN:BUDA – Get Free Report) last posted its quarterly earnings results on Friday, August 14th. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $4.51 million during the quarter. On average, equities research analysts forecast that BUDA will post 0.11 EPS for the current year.

BUDA Company Profile

(Get Free Report)

Buda Juice, Inc (NYSE American: BUDA) is a beverage company focused on producing and selling organic, cold-pressed juice products. Its offerings are designed to provide convenient, ready-to-consume beverages made from fruit, vegetables and other plant-based ingredients.

The company’s product portfolio includes cold-pressed juice shots and related functional beverage products, with formulations intended to support wellness and everyday nutrition. Buda Juice products are marketed through retail, natural and specialty food channels, as well as other distribution outlets.

Buda Juice serves consumers seeking refrigerated, minimally processed and plant-based beverage options.

Further Reading

Receive News & Ratings for BUDA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BUDA and related companies with MarketBeat.com's FREE daily email newsletter.